Anna Aalbers

Anna Aalbers is a Researcher at the Department of Hematology, Erasmus MC. Her work focuses on oncology, hematology, and surgical oncology with expertise in colorectal cancer, pelvic exenteration surgery, and genetic aspects of autoimmune disorders like VEXAS syndrome.

Her research interests include the clinical and genetic remission of VEXAS syndrome, surgical standards for pelvic exenteration, long-term outcomes of rectal cancer surgeries, and prognostic factors in cancer therapy. She has contributed to collaborative guidelines such as the PelvEx standards and conducted studies on lymph node analysis in rectal cancer patients.

Key publications include groundbreaking work on azacitidine treatment for VEXAS syndrome and surgical outcome analyses in colorectal cancer. Her work emphasizes multidisciplinary approaches to cancer care and evidence-based surgical practices.

Anna collaborates internationally through initiatives like the PelvEx Collaborative and Dutch Snapshot Research Group. While no formal awards are listed, her research has been widely cited and referenced in policy documents.